As of March 10, “30 cases” of adverse side effects have been reported after the administration of the AstraZeneca vaccine against Covid-19, out of nearly five million people vaccinated.
Emer Cooke, director of the European Medicines Agency (EMA), explained this at a press conference in Brussels. "But there were additional cases reported over the weekend, so this figure is likely an underestimate," she added.
Read also here
The benefits of the vaccine AstraZeneca outweigh the risks. The executive director of the European Medicines Agency (EMA), Emer Cooke, said this at a press conference. “The benefits of this vaccine outweigh the risks. That is the conclusion of our scientific assessment,” she said. “We have more information and if that changes we will come to a clear conclusion,” Cooke added.
“A situation like this is not unexpected: when you vaccinate millions of people, it is inevitable that rare or serious episodes of illness will occur after vaccination”. This was stated by the director of the EMA, Emer Cooke, during a press conference called to indicate the verification path on the AstraZeneca vaccine. “The role of the EMA – continued Cooke – is to evaluate” the suspected cases “to make sure that any adverse reactions are investigated quickly so that we can understand whether it is a true side effect of the vaccine or a coincidence”.
EDITORIAL TEAM
Choose the social channel you want to subscribe to